LIGAND PHARMACEUTICALS INC
Pharmaceutical Preparations | SIC: 2834Phone: 858-550-7500
EIN: 770160744
State Location: CA
State of Inc.: DE
- Nasdaq:LGND
- OTC:LGNDZ
- OTC:LGNXZ
- OTC:LGNYZ
- OTC:LGNZZ
Form: 10-Q
Filing Date: 08 May 2026Report Date: 31 Mar 2026
Accepted: 08 May 2026 02:14 p.m.
Accession Number: 0000886163-26-000034
File Number: 001-33093
Film Number: 26958503
Documents
Primary Document: 10-Q
Accepted: 08 May 2026 02:14 p.m.
0000886163-26-000034-index-headers.html
Last Modified: 08 May 2026 02:14 p.m.
0000886163-26-000034-index.html
Last Modified: 08 May 2026 02:14 p.m.
0000886163-26-000034.txt
Last Modified: 08 May 2026 02:14 p.m.
0000886163-26-000034-xbrl.zip
Last Modified: 08 May 2026 02:14 p.m.
FilingSummary.xml
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331.xsd
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331_cal.xml
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331_def.xml
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331_g1.jpg
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331_htm.xml
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331_lab.xml
Last Modified: 08 May 2026 02:14 p.m.
lgnd-20260331_pre.xml
Last Modified: 08 May 2026 02:14 p.m.
lgnd_33126exhibit311.htm
Last Modified: 08 May 2026 02:14 p.m.
lgnd_33126exhibit312.htm
Last Modified: 08 May 2026 02:14 p.m.
lgnd_33126exhibit321.htm
Last Modified: 08 May 2026 02:14 p.m.
MetaLinks.json
Last Modified: 08 May 2026 02:14 p.m.
R1.htm
Last Modified: 08 May 2026 02:14 p.m.
R10.htm
Last Modified: 08 May 2026 02:14 p.m.
R11.htm
Last Modified: 08 May 2026 02:14 p.m.
R12.htm
Last Modified: 08 May 2026 02:14 p.m.
R13.htm
Last Modified: 08 May 2026 02:14 p.m.
R14.htm
Last Modified: 08 May 2026 02:14 p.m.
R15.htm
Last Modified: 08 May 2026 02:14 p.m.
R16.htm
Last Modified: 08 May 2026 02:14 p.m.